PseudoCyc, A Pathway-Genome Database for Pseudomonas aeruginosaRomero P. · Karp P.
Bioinformatics Research Group, SRI International, Menlo Park, Calif., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
A pathway-genome database (PGDB) describes the entire genome of an organism, as well as its biochemical pathways, reactions, and enzymes. Our PathoLogic software can generate a PGDB from an annotated genome of an organism, predicting the metabolic reactions and pathways corresponding to the enzymes present in the annotation. We have used PathoLogic to generate a PGDB for Pseudomonas aeruginosa, strain PAO1, called ‘PseudoCyc’, which includes 139 predicted pathways and 800 predicted reactions involving 623 chemical species and 718 enzymes. Analysis of the PathoLogic predictions of arginine metabolism and the β-ketoadipate pathway, which are landmark pathways in P. aeruginosa, showed that they were for the most part correctly predicted. These studies also provided possible locations for two genes involved in the β-ketoadipate pathway, pcaI and pcaJ, which are missing from the PAO1 annotation. PseudoCyc adds an extended dimension to the genome of P. aeruginosa, providing researchers with a helpful tool for the analysis of the genomic, proteomic, and metabolic information of the organism. The finding of the probable location of the pcaI and pcaJ genes is but one example of the discoveries facilitated by such a PGDB. PseudoCyc, along with PGDBs for 12 other organisms, is available at http://BioCyc.org/.
© 2003 S. Karger AG, Basel
Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D.J. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402.
Gobel, M., Kassel-Cati, K., Schmidt, E., and Reineke, W. 2002. Degradation of aromatics and chloroaromatics by Pseudomonas sp. strain B13:cloning, characterization, and analysis of sequences encoding 3-oxoadipate:succinyl-coenzyme A (CoA) transferase and 3-oxoadipyl-CoA thiolase. J. Bacteriol. 184:216–223.
Haas, D., Galimand, M., Gamper, M., and Zimmermann, A. 1990. Arginine network of Pseudomonas aeruginosa: Specific and global controls; In: Pseudomonas: Biotransformations, Pathogenesis, and Evolving Biotechnology. Silver S., Chakrabarti A., Iglewski B., and Kaplan S, eds. American Society for Microbiology, Washington, pp. 303–316.
Haas, D., Matsumoto, H., Moretti, P., Stalon, V., and Mercenier, A. 1984. Arginine degradation in Pseudomonas aeruginosa mutants blocked in two arginine catabolic pathways. Mol. Gen. Genet. 193:437–444.
Karp, P.D. 2001. Pathway databases: A case study in computational symbolic theories. Science 293:2040–2044.
Karp, P.D., Paley, S., and Romero, P.R. 2002. The Pathway Tools software. Bioinformatics 18(suppl 1):S225–S232.
Karp, P.D., Riley, M., Saier, M., Paulsen, I.T., Paley, S.M., and Pellegrini-Toole, A. 2000. The EcoCyc and MetaCyc databases. Nucleic Acids Res. 28:56–59.
Nakada, Y., Jiang, Y., Nishijyo, T., Itoh, Y., and Lu, C.D. 2001. Molecular characterization and regulation of the aguBA operon, responsible for agmatine utilization in Pseudomonas aeruginosa PAO1. J. Bacteriol. 183:6517–6524.
Ouzounis, C.A., and Kyrpides, N.C. 1994. On the evolution of arginases and related enzymes. J. Mol. Evol. 39:101–104.
Paley, S., and Karp, P.D. 2002. Evaluation of computational metabolic-pathway predictions for Helicobacter pylori. Bioinformatics 18:715–724.
Park, S.M., Lu, C.D., and Abdelal, A.T. 1997. Cloning and characterization of argR, a gene that participates in regulation of arginine biosynthesis and catabolism in Pseudomonas aeruginosa PAO1. J. Bacteriol. 179:5300–5308.
Parke, D., D’Argenio, D.A., and Ornston, L.N. 2000. Bacteria are not what they eat: that is why they are so diverse. J. Bacteriol. 182:257–263.
Stover, C.K., Pham, X.Q., Erwin, A.L., Mizoguchi, S.D., Warrener, P., Hickey, M.J., Brinkman, F.S., Hufnagle, W.O., Kowalik, D.J., Lagrou, M., Garber, R.L., Goltry, L., Tolentino, E., Westbrock-Wadman, S., Yuan, Y., Brody, L.L., Coulter, S.N., Folger, K.R., Kas, A., Larbig, K., Lim, R., Smith, K., Spencer, D., Wong, G.K., Wu, Z., and Paulsen, I.T. 2000. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406:959–964.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.